Skip to content
  • HOME
  • CONTACT US
  • CAREERS
  • ONLINE TRADING PORTAL
  • English
  • 中文
Crosby

Crosby

Menu

  • NEWS & ANNOUNCEMENTS
    • SHOW ALL
    • NEWS
    • ANNOUNCEMENT
    • RESEARCH
    • EVENTS
  • WHAT WE DO
    • SALES & TRADING
    • CORPORATE FINANCE
    • ASSET MANAGEMENT
    • WEALTH MANAGEMENT
  • ABOUT US
    • THE FIRM
    • HISTORY
    • TRANSACTIONS
    • SOCIAL RESPONSIBILITY

    RESEARCH

    CROSBY Research – Vincent Medical (1612 HK/BUY): Staging a turnaround in 1H23

    CROSBY Research – Vincent Medical (1612 HK/BUY): Staging a turnaround in 1H23

    24 Aug 2023 In 1H23, Vincent Medical’s (VM) sales increased by 28.7% YoY to HK$361.2m. GPM jumped from 13.1% to 32.9% in 1H23, representing an impressive YoY improvement of 19.8ppt. This was mainly due to the decrease in allowance for

    Crosby_research August 24, 2023 RESEARCH Read more

    CROSBY Research – Pagoda (2411 HK): Widening NPM on operational efficiency and cost savings

    CROSBY Research – Pagoda (2411 HK): Widening NPM on operational efficiency and cost savings

    22 Aug 2023 The company reported a 6.4% YoY increase in topline to Rmb6,294m in 1H23, with sales of fruits and food products up by 6.7% YoY to Rmb6,117m. The sales increase was driven by i) a 9.3% YoY increase

    Crosby_research August 22, 2023 RESEARCH Read more

    CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 41)

    CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 41)

    21 Aug 2023 Hong Kong’s population has grown 2.1% on the year to almost 7.5 million people, as arrivals from mainland China and elsewhere after the pandemic helped reverse a decline that started in 2020, as reported by Nikkei. HK

    Crosby_research August 21, 2023August 21, 2023 RESEARCH Read more

    CROSBY Research – China Lilang (1234 HK): Single digit growth in 1H23

    CROSBY Research – China Lilang (1234 HK): Single digit growth in 1H23

    18 Aug 2023 The company reported a 6.7% YoY increase in topline to Rmb1,491m in 1H23, with i) core collection slightly increased by 3.2% YoY amid higher sales throughout rate and ASP hike in 2H22, partially offset by orders reduction

    Crosby_research August 18, 2023August 18, 2023 RESEARCH Read more

    CROSBY Research – 361 Degrees (1361 HK/BUY): Promising outlook

    CROSBY Research – 361 Degrees (1361 HK/BUY): Promising outlook

    17 Aug 2023 1H23 revenue increased by 18.0% YoY to Rmb4.31bn, with core brand retail value up by low-teens/low-teens YoY and that of 361º Kids up by +20-25%/+20-25% YoY in 1Q/2Q. GPM edged up by 0.2ppt YoY to 41.7%, as

    Crosby_research August 17, 2023August 17, 2023 RESEARCH Read more

    CROSBY Research – Pentamaster (1665 HK/BUY): Steady 2Q23 revenue growth, medical devices will drive 2H23 momentum

    CROSBY Research – Pentamaster (1665 HK/BUY): Steady 2Q23 revenue growth, medical devices will drive 2H23 momentum

    16 Aug 2023 Pentamaster’s 2Q23 revenue increased 16.8% YoY from MYR151.3m in 2Q22 to MYR176.8m. Automated Test Equipment (ATE) segment revenue surged 35.0% YoY to MYR148.5m on strong demand for EV product solutions. Factory Automation Solutions (FAS) segment revenue declined

    Crosby_research August 16, 2023 RESEARCH Read more

    CROSBY Research – Greentech(1257 HK/BUY): Increasing EBITDA for its biomass segment

    CROSBY Research – Greentech(1257 HK/BUY): Increasing EBITDA for its biomass segment

    15 Aug 2023 CEG’s 1H23 revenue was down by 9% YoY to HK$3,820m, driven by a mixture of factors: 1) 43% YoY decrease in HWT business on the back of -15%/-89% YoY in operation /construction revenue; 2) 0.3% increase in

    Crosby_research August 15, 2023 RESEARCH Read more

    CROSBY Research – SIIC (807 HK): Growth driven by the new Baoshan project

    CROSBY Research – SIIC (807 HK): Growth driven by the new Baoshan project

    14 Aug 2023 SIIC’s 1H23 revenue increased by 9.0% YoY to Rmb4.02bn, mainly driven by 1) 12.1% YoY increase in operation segment including operating and maintenance income & financial income from service concession arrangements as the Baoshan Project commenced operation

    Crosby_research August 14, 2023August 14, 2023 RESEARCH Read more

    CROSBY Research – Q-Tech (1478 HK/BUY): Expect the recovery trajectory to maintain in 2H23, maintain BUY rating

    CROSBY Research – Q-Tech (1478 HK/BUY): Expect the recovery trajectory to maintain in 2H23, maintain BUY rating

    11 Aug 2023 Q-Tech reported 1H23 revenue of Rmb5,477m, which decreased 22.8% YoY. 1H23 total CCM shipment decreased 20.2% YoY to 170.0m units with ASP declined 3.8% YoY to Rmb29.4. FPM shipment stayed flat YoY in 1H23 with ASP plunged

    Crosby_research August 11, 2023August 14, 2023 RESEARCH Read more

    CROSBY Research – TMT sector: Review of 2Q23 smartphone shipment and market share

    CROSBY Research – TMT sector: Review of 2Q23 smartphone shipment and market share

    07 Aug 2023 According to the latest data from IDC, despite global smartphone shipment contracted for the eighth consecutive quarter to 265.3mn units in 2Q23, the rate of decline has gradually slowed from a contraction of 18.3%/ 14.6% YoY in

    Crosby_research August 7, 2023August 7, 2023 RESEARCH Read more
    • « Previous
    • Next »

    NEWS & ANNOUNCEMENTS

    • Show All
    • News
    • Announcement
    • Research
    • Events

    WHAT WE DO

    • Sales & Trading
    • Corporate Finance
    • Asset Management
    • Wealth Management

    ABOUT US

    • The Firm
    • History
    • Transactions
    • Social Responsibility
    Copyright © 2026 Crosby. All rights reserved. Theme Spacious by ThemeGrill. Powered by: WordPress.